HIV in prison: what are the risks and what can be done?
- PMID: 16334992
- DOI: 10.1071/sh03018
HIV in prison: what are the risks and what can be done?
Abstract
Prisons are recognised worldwide as important sites for transmission of blood-borne viruses (BBVs). There are two reasons why transmission risks in prison are higher than in the community. First, in most western countries, many prison entrants have histories of injecting drug use, and thus already have high prevalences of BBVs. Second, the lack or under-supply of preventive measures (such as clean needle and syringes or condoms) in most prisons, combined with extreme social conditions, creates extra opportunities for BBV transmission. HIV prevalence in prisoners in more developed countries ranges from 0.2% in Australia to over 10% in some European nations. There are case reports of HIV being transmitted by sharing injecting equipment and sexual activity. Tattooing has been reported as a risk factor for the transmission of BBVs in prison. Access to condoms and needle and syringe programmes in prisons is extremely limited, despite success when they have been introduced. The vast majority of prison inmates are incarcerated for only a few months before returning to the community--thus they are, over the long term, more appropriately regarded as 'citizens' than 'prisoners'. Public health policy must involve all sections of the community, including prison inmates, if we are to reduce transmission of HIV and other BBVs.
Similar articles
-
Tattooing in prisons--not such a pretty picture.Am J Infect Control. 2007 Sep;35(7):477-80. doi: 10.1016/j.ajic.2006.08.002. Am J Infect Control. 2007. PMID: 17765561
-
Prevalence of Drug Injection, Sexual Activity, Tattooing, and Piercing Among Prison Inmates.Epidemiol Rev. 2018 Jun 1;40(1):58-69. doi: 10.1093/epirev/mxy002. Epidemiol Rev. 2018. PMID: 29860343
-
Injecting substance use in prisons in the United States: a case for needle exchange programs.Am J Drug Alcohol Abuse. 2021 May 4;47(3):273-279. doi: 10.1080/00952990.2021.1872587. Epub 2021 Feb 17. Am J Drug Alcohol Abuse. 2021. PMID: 33596124
-
Within-prison drug injection among HIV-infected Ukrainian prisoners: prevalence and correlates of an extremely high-risk behaviour.Int J Drug Policy. 2014 Sep;25(5):845-52. doi: 10.1016/j.drugpo.2014.02.010. Epub 2014 Feb 28. Int J Drug Policy. 2014. PMID: 24951025 Free PMC article.
-
Interventions to reduce HIV transmission related to injecting drug use in prison.Lancet Infect Dis. 2009 Jan;9(1):57-66. doi: 10.1016/S1473-3099(08)70305-0. Lancet Infect Dis. 2009. PMID: 19095196 Review.
Cited by
-
Controversies in and challenges to our understanding of hepatitis C.World J Gastroenterol. 2007 Aug 21;13(31):4168-76. doi: 10.3748/wjg.v13.i31.4168. World J Gastroenterol. 2007. PMID: 17696244 Free PMC article. Review.
-
Harm reduction and equity of access to care for French prisoners: a review.Harm Reduct J. 2008 May 21;5:17. doi: 10.1186/1477-7517-5-17. Harm Reduct J. 2008. PMID: 18495018 Free PMC article.
-
Prevalence of HCV risk behaviors among prison inmates: tattooing and injection drug use.J Health Care Poor Underserved. 2011 Aug;22(3):962-82. doi: 10.1353/hpu.2011.0084. J Health Care Poor Underserved. 2011. PMID: 21841290 Free PMC article.
-
Correlates of Mandrax use and condom beliefs in preventing sexually transmitted infections among a cohort of South African prison inmates.Int Health. 2016 Mar;8(2):142-7. doi: 10.1093/inthealth/ihv048. Epub 2015 Aug 27. Int Health. 2016. PMID: 26316220 Free PMC article.
-
Imprisoned and imperiled: access to HIV and TB prevention and treatment, and denial of human rights, in Zambian prisons.J Int AIDS Soc. 2011 Feb 11;14:8. doi: 10.1186/1758-2652-14-8. J Int AIDS Soc. 2011. PMID: 21314929 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical